Natural Capsules (BOM:524654) Piotroski F-Score: 4 (As of Aug. 09, 2026) — 20% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524654 Natural Capsules Ltd BOM:524654
46 GF Score
Price ₹155.80
GF Value ₹313.68
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Natural Capsules Piotroski F-Score?

Natural Capsules BOM:524654 +3.42% 46 Piotroski F-Score is 4 as of Aug. 09, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates BOM:524654 with a GF Score™ of 46/100 and a GF Value™ of ₹313.68 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 977 Drug Manufacturers companies, Natural Capsules ranks worse than 61.11% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Natural Capsules has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Natural Capsules's Piotroski F-Score or its related term are showing as below:

BOM:524654' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 9
Current: 4

During the past 13 years, the highest Piotroski F-Score of Natural Capsules was 9. The lowest was 2. And the median was 5.

Natural Capsules  (BOM:524654) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Natural Capsules Piotroski F-Score Related Terms


Natural Capsules Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Natural Capsules's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natural Capsules Piotroski F-Score Chart

Natural Capsules Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 2.00 3.00 5.00 4.00

Natural Capsules Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 0.00 0.00 4.00

BOM:524654 vs ZTS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Natural Capsules's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natural Capsules Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natural Capsules's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Natural Capsules's Piotroski F-Score falls into.


BOM:524654
46GF Score
Natural Capsules Ltd BOM:524654
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹-247 Mil.
Cash Flow from Operations was ₹109 Mil.
Revenue was ₹1,831 Mil.
Gross Profit was ₹756 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (4193.515 + 4241.578) / 2 = ₹4217.5465 Mil.
Total Assets at the begining of this year (Mar25) was ₹4,194 Mil.
Long-Term Debt & Capital Lease Obligation was ₹554 Mil.
Total Current Assets was ₹1,368 Mil.
Total Current Liabilities was ₹1,327 Mil.
Net Income was ₹6 Mil.

Revenue was ₹1,642 Mil.
Gross Profit was ₹757 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (3765.252 + 4193.515) / 2 = ₹3979.3835 Mil.
Total Assets at the begining of last year (Mar24) was ₹3,765 Mil.
Long-Term Debt & Capital Lease Obligation was ₹574 Mil.
Total Current Assets was ₹1,296 Mil.
Total Current Liabilities was ₹1,000 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Natural Capsules's current Net Income (TTM) was -247. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Natural Capsules's current Cash Flow from Operations (TTM) was 109. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-246.634/4193.515
=-0.05881319

ROA (Last Year)=Net Income/Total Assets (Mar24)
=6.174/3765.252
=0.00163973

Natural Capsules's return on assets of this year was -0.05881319. Natural Capsules's return on assets of last year was 0.00163973. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Natural Capsules's current Net Income (TTM) was -247. Natural Capsules's current Cash Flow from Operations (TTM) was 109. ==> 109 > -247 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=554.444/4217.5465
=0.13146127

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=574.252/3979.3835
=0.14430678

Natural Capsules's gearing of this year was 0.13146127. Natural Capsules's gearing of last year was 0.14430678. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1368.003/1327.302
=1.03066446

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1295.873/999.926
=1.2959689

Natural Capsules's current ratio of this year was 1.03066446. Natural Capsules's current ratio of last year was 1.2959689. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Natural Capsules's number of shares in issue this year was 10.372. Natural Capsules's number of shares in issue last year was 9.836. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=756.207/1830.881
=0.41302903

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=757.254/1641.512
=0.46131493

Natural Capsules's gross margin of this year was 0.41302903. Natural Capsules's gross margin of last year was 0.46131493. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=1830.881/4193.515
=0.43659818

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=1641.512/3765.252
=0.43596338

Natural Capsules's asset turnover of this year was 0.43659818. Natural Capsules's asset turnover of last year was 0.43596338. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Natural Capsules has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Natural Capsules (BOM:524654) has a Piotroski F-Score of 4 as of Aug. 09, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Natural Capsules and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, Natural Capsules' Piotroski F-Score has ranged from 2.00 to 9.00. According to the industry distribution chart, Natural Capsules ranks #597 out of 977 companies in the Drug Manufacturers industry, placing it in the top 61.1%.
Is Natural Capsules' Piotroski F-Score too high?
Natural Capsules' current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 9.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Natural Capsules' value of 4 is 20% below this industry median. Based on the distribution chart, Natural Capsules ranks #597 out of 977 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Natural Capsules has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Natural Capsules' Piotroski F-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Natural Capsules ranks #597 out of 977 companies for Piotroski F-Score. This places Natural Capsules in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Natural Capsules' value of 4 is 20% below this benchmark. Historically, Natural Capsules' own Piotroski F-Score has ranged from 2.00 to 9.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Natural Capsules has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 977 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Natural Capsules's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Natural Capsules and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Natural Capsules's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Capsules stock overvalued right now?
Based on GuruFocus' analysis, Natural Capsules (BOM:524654) is currently considered Possible Value Trap. The stock's GF Value™ is ₹313.68, compared to a current price of ₹155.80 — trading 50.3% below its estimated fair value. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 20% below the Drug Manufacturers industry median of 5.00. Natural Capsules' overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Natural Capsules (BOM:524654), the current Piotroski F-Score is 4 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Natural Capsules (BOM:524654) Overvalued in 2026?

Based on GuruFocus' analysis, Natural Capsules stock appears to be undervalued. The current stock price of ₹155.80 is trading 50.3% below its estimated GF Value™ of ₹313.68. GuruFocus considers Natural Capsules to be Possible Value Trap.

Key valuation signals for BOM:524654:

  • Piotroski F-Score: 4 (20% below median its 10-year median of 5.00)
  • GF Value™: ₹313.68 vs. price of ₹155.80 (50.3% below fair value)
  • GF Score™: 46/100 with 4 warning signs
  • Industry Position: 20% below the Drug Manufacturers median (#597 of 977)

No single metric tells the full story. See the BOM:524654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Natural Capsules Business Description

Other Exchanges NATCAPSUQ:India
Address 100 Feet Road, Jayanagar II Block, Trident Towers, 4th Floor, No. 23, Bengaluru, KA, IND, 560 011
Natural Capsules Ltd is an India-based company engaged in the manufacturing and selling of empty hard gelatin capsules. The products of the company are Hard gelatin capsule shells, Hard cellulose capsule shells, Shiny gelatin capsule shells, Sweet gelatin capsule shells, Enteric capsule shells, Printed gelatin capsule shells, Vegetarian capsule shells, Fortified gelatin capsule shells, and other capsules. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form, both pharma and nutraceutical products.
46GF Score

Get the complete analysis for BOM:524654

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹155.80
Price
₹313.68
GF Value